← Eichor
Condition: Severe Diabetic Macular Oedema Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Severe Diabetic Macular Oedema

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without C
Phase 2/Phase 3 · 15 location(s) · AbbVie · NCT07592273Anti-vascular Endothelial Growth Factor (Anti-VEGF) Monotherapy vs Anti-VEGF Followed by Subthreshold Micropulse Laser f
Phase 3 · 22 location(s) · Belfast Health and Social Care Trust · NCT06985706
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.